Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation
Clinical trial NCT00253214 · COMPLETED
Trial details
- NCT number
- NCT00253214
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-03-01
- Enrollment
- 973
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.